Effects of fluvastatin (XU 62-320), an HMG-CoA reductase inhibitor, on the distribution and composition of low density lipoprotein subspecies in humans-Reference-Cited by-同舟云学术

Effects of fluvastatin (XU 62-320), an HMG-CoA reductase inhibitor, on the distribution and composition of low density lipoprotein subspecies in humans

Published:1991-04 Issue:2-3 Volume:87 Page:147-157
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Yuan Jiana,Tsai Michael Y.,Hegland Janet,Hunninghake Donald B.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference18 articles.

1. Lowering blood cholesterol to prevent heart disease;Consensus Conference;JAMA,1985

2. The Lipid Research Clinics Coronary Primary Prevention Trials Results;Lipid Research Clinics;JAMA,1984

3. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel

4. HMG-CoA reductase inhibitors for treatment of hypercholesterolemia;Grundy;N. Engl. J. Med.,1988

5. Clinical trials of lovastatin and simvastatin versus cholestyramine;Hunninghake;Atheroscler. Rev.,1988

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Statins and Hemostasis: Therapeutic Potential Based on Clinical Evidence;Advances in Experimental Medicine and Biology;2023

2. Fluvastatin for lowering lipids;Cochrane Database of Systematic Reviews;2018-03-06

3. Safety of fluvastatin in patients undergoing high-risk non-cardiac surgery;Expert Opinion on Drug Safety;2010-06-17

4. Genetic and environmental influences on LDL subclass phenotypes;Clinical Genetics;2008-06-28

5. Cholesterol modulates cellular TGF-β responsiveness by altering TGF-β binding to TGF-β receptors;Journal of Cellular Physiology;2008-04